Radical surgical removal of the prostate is the most frequent treatment for prostate cancer when the tumour is localised (meaning it has not spread outside the prostate). 

This workshop brings together agency, regulator, industry and primary researcher communities in biomedical sciences to talk freely about methods and models and explore common ground.

This is a Champalimaud Foundation workshop co-organised with CONGENTO and QuantOCancer projects, the Joint Research Centre (JRC) and FRESCI.

During this event we will:

The starting point for the discussion was the “Inside the Unknown” Science Collection, a project developed by this group in collaboration with Champalimaud Research Labs. The genesis of the project, the creative process behind it, the articulation of all the team’s expertises, main challenges and evaluation metrics, were some of the topics addressed in this conversation.

Champalimaud Foundation’s work with artificial intelligence is the fourth best in the worldIn the Nature TOP 10, there are institutions from Germany, the United States of America, Portugal, the Netherlands, Spain and the United Kingdom. According to Leonor Beleza, President of the Champalimaud Foundation, “it is a great honour for Portugal and for the Champalimaud Foundation to be at the forefront of scientific research”.

The panel included three in-house specialists: immunologist Thiago Carvalho and oncologists Fátima Cardoso, head of the Breast Unit at the Champalimaud Clinical Centre, and Cristina João, a haematologist in the Haemato-Oncology Unit who also heads the Myeloma and Lymphoma Research Lab at Champalimaud Research.

Cancer researcher Rita Fior uses zebrafish to study human cancer. Though this may seem like an unlikely match, her work shows great promise with forthcoming applications in personalised medicine. 

The basic principle of Fior's approach relies on transplanting human cancer cells into dozens of zebrafish larvae. The fish then serve as "living test tubes" where various treatments, such as different chemotherapy drugs, can be tested to reveal which works best. The assay is rapid, producing an answer within four short days.

Um ano após o início da Pandemia de COVID-19, a doença continua a ter um forte impacto na vida das pessoas, nomeadamente naqueles que manifestam maior risco e suscetibilidade a doenças graves, por apresentarem comorbidades, como é o caso dos doentes oncológicos.

The INPDP provides students with an integrative, state-of-the-art education in either Neuroscience or Physiology & Cancer. Top evaluated candidates will receive full financial support to participate in classes and conduct research for 5 years with possible extensions.

Studies have suggested for years that dogs are masters at detecting disease thanks to their exceptional sense of smell. Experts agree that their success most probably lies in their ability to sniff out so-called volatile organic compounds, or VOCs, in the air people exhale. In the last few years, more than 1,000 VOCs have been identified in human breath, and scientists are now seeking to determine which ones could be relevant cancer biomarkers.